Deciphering the Warburg Effect: Metabolic Reprogramming, Epigenetic Remodeling, and Cell Dedifferentiation

被引:5
|
作者
Li, Albert M. [1 ,2 ,3 ]
Ye, Jiangbin [2 ,4 ]
机构
[1] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA
[2] Stanford Univ, Canc Biol Program, Sch Med, Stanford, CA 94305 USA
[3] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Immunol, New York, NY 10065 USA
[4] Stanford Univ, Stanford Canc Inst, Sch Med, Stanford, CA USA
来源
ANNUAL REVIEW OF CANCER BIOLOGY | 2024年 / 8卷
关键词
Warburg effect; cancer metabolism; differentiation; epigenetics; mitochondria uncoupling; symbiogenesis; GASTROINTESTINAL STROMAL TUMORS; MITOCHONDRIAL PYRUVATE CARRIER; FUMARATE-HYDRATASE; DNA DEMETHYLATION; ACETATE SUPPLEMENTATION; SPONTANEOUS REGRESSION; HISTONE DEMETHYLATION; GENE-EXPRESSION; IDH2; MUTATIONS; SDH MUTATIONS;
D O I
10.1146/annurev-cancerbio-062822-120857
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A century ago, Otto Heinrich Warburg made a seminal discovery now known as the Warburg effect. This metabolic signature, prevalent across all cancer cells, is characterized by the prominent shift of glucose metabolism toward lactate production instead of oxidative respiration. Warburg's pioneering theory suggested that the induction of the Warburg effect instigates dedifferentiation and the process of tumorigenesis, illuminating a fundamental mechanism underlying cancer development. To celebrate the centennial anniversary of Warburg's monumental finding, it is an appropriate moment to reflect upon and commemorate his revolutionary contributions to the fields of metabolism and cancer research. In this review, we explore the role of mitochondria in epigenetic regulation and the decisions governing cell fate from an evolutionary standpoint. Moreover, we summarize metabolic and genetic factors that trigger the Warburg effect, underscoring the therapeutic potential of mitochondrial uncoupling as a strategy to counter this metabolic aberration. Our goal is to elucidate the means to induce tumor differentiation through metabolic therapy, thereby laying a foundation toward the cure for cancer.
引用
收藏
页码:35 / 58
页数:24
相关论文
共 50 条
  • [21] FLCN: A new regulator of AMPK-dependent Warburg metabolic reprogramming
    Gingras, Marie-Claude
    Pause, Arnim
    MOLECULAR & CELLULAR ONCOLOGY, 2014, 1 (02):
  • [22] Cisplatin-Resistant Urothelial Bladder Cancer Cells Undergo Metabolic Reprogramming beyond the Warburg Effect
    Afonso, Julieta
    Barbosa-Matos, Catarina
    Silvestre, Ricardo
    Pereira-Vieira, Joana
    Goncalves, Samuel Martins
    Mendes-Alves, Camille
    Parpot, Pier
    Pinto, Joana
    Carapito, Angela
    de Pinho, Paula Guedes
    Santos, Lucio
    Longatto-Filho, Adhemar
    Baltazar, Fatima
    CANCERS, 2024, 16 (07)
  • [23] Itaconate ameliorates autoimmunity by modulating T cell imbalance via metabolic and epigenetic reprogramming
    Aso, Kuniyuki
    Kono, Michihito
    Kanda, Masatoshi
    Kudo, Yuki
    Sakiyama, Kodai
    Hisada, Ryo
    Karino, Kohei
    Ueda, Yusho
    Nakazawa, Daigo
    Fujieda, Yuichiro
    Kato, Masaru
    Amengual, Olga
    Atsumi, Tatsuya
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [24] Epigenetic and metabolic reprogramming of SDH-deficient paragangliomas
    Moog, Sophie
    Lussey-Lepoutre, Charlotte
    Favier, Judith
    ENDOCRINE-RELATED CANCER, 2020, 27 (12) : R451 - R463
  • [25] Reciprocal Regulation of Metabolic Reprogramming and Epigenetic Modifications in Cancer
    Yu, Xian
    Ma, Rui
    Wu, Yinsheng
    Zhai, Yansheng
    Li, Shanshan
    FRONTIERS IN GENETICS, 2018, 9
  • [26] Metabolic Controls on Epigenetic Reprogramming in Regulatory T Cells
    Lu, Jingli
    Liang, Yan
    Meng, Haiyang
    Zhang, Ailing
    Zhao, Junjie
    Zhang, Chengliang
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [27] LncRNAs in tumor metabolic reprogramming and tumor microenvironment remodeling
    Jiao, Jianhang
    Zhao, Yangzhi
    Li, Qimei
    Jin, Shunzi
    Liu, Zhongshan
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [28] Metabolic and Epigenetic Reprogramming in a Case of Nuclear Protein in Testis (NUT) Carcinoma of the Retroperitoneum
    Serizawa, Mika
    Serizawa, Kaho
    Masui, Kenta
    Toguchi, Makoto
    Murakami, Kumiko
    Yamamoto, Tomoko
    Nagashima, Yoji
    Takagi, Toshio
    Kurata, Atsushi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [29] Metabolic Reprogramming Drives Pituitary Tumor Growth through Epigenetic Regulation of TERT
    Onizuka, Hiromi
    Masui, Kenta
    Amano, Kosaku
    Kawamata, Takakazu
    Yamamoto, Tomoko
    Nagashima, Yoji
    Shibata, Noriyuki
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 2021, 54 (03) : 87 - 96
  • [30] Biophysical regulation of epigenetic state and cell reprogramming
    Downing, Timothy L.
    Soto, Jennifer
    Morez, Constant
    Houssin, Timothee
    Fritz, Ashley
    Yuan, Falei
    Chu, Julia
    Patel, Shyam
    Schaffer, David V.
    Li, Song
    NATURE MATERIALS, 2013, 12 (12) : 1154 - 1162